Author: | Joyce, J. A. |
Article Title: | Therapeutic targeting of the tumor microenvironment |
Keywords: | cancer chemotherapy; unclassified drug; lenalidomide; thalidomide; clinical trial; review; angiogenesis inhibitor; bevacizumab; sunitinib; drug safety; nonhuman; side effect; antineoplastic agents; alpha interferon; cancer radiotherapy; pancreas cancer; glioma; antineoplastic agent; neoplasms; colorectal cancer; imatinib; cancer prevention; breast cancer; models, biological; basement membrane; lung non small cell cancer; inflammation; lung cancer; vasculotropin inhibitor; bladder cancer; carcinogenesis; protein tyrosine kinase inhibitor; endothelium cell; extracellular matrix; lung metastasis; endothelium, vascular; cyclooxygenase 2 inhibitor; nonsteroid antiinflammatory agent; uterine cervix cancer; chronic pancreatitis; combretastatin a4; vandetanib; vatalanib; neoplasm metastasis; stroma; stomach cancer; liver cancer; target cell; innate immunity; microenvironment; tumor vascularization; cell communication; helicobacter pylori; enzastaurin; chronic inflammation; drug delivery system; suramin; biological availability; 2 methoxyestradiol; cilengitide; angiostatin; matrix metalloproteinase inhibitor; atrasentan; volociximab; pericyte; neutralizing antibody; helicobacter infection; endostatin; pi 88; helicobacter; ae 941; sibrotuzumab; monoclonal antibody lm 609; platelet derived growth factor receptor inhibitor; transforming growth factor beta inhibitor; pericytes |
Journal Title: | Cancer Cell |
Volume: | 7 |
Issue: | 6 |
ISSN: | 1535-6108 |
Publisher: | Cell Press |
Date Published: | 2005-06-01 |
Start Page: | 513 |
End Page: | 520 |
Language: | English |
DOI: | 10.1016/j.ccr.2005.05.024 |
PUBMED: | 15950901 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 159" - "Export Date: 24 October 2012" - "CODEN: CCAEC" - "Source: Scopus" |